These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 26782772

  • 1. Novel adjuvant strategy to potentiate bacitracin against MDR MRSA.
    Kim JC, Jeon B.
    J Antimicrob Chemother; 2016 May; 71(5):1260-3. PubMed ID: 26782772
    [Abstract] [Full Text] [Related]

  • 2. Antioxidant-based synergistic eradication of methicillin-resistant Staphylococcus aureus (MRSA) biofilms with bacitracin.
    Oh E, Bae J, Kumar A, Choi HJ, Jeon B.
    Int J Antimicrob Agents; 2018 Jul; 52(1):96-99. PubMed ID: 29567095
    [Abstract] [Full Text] [Related]

  • 3. Anti-MRSA activity of alkyl gallates.
    Kubo I, Xiao P, Fujita K.
    Bioorg Med Chem Lett; 2002 Jan 21; 12(2):113-6. PubMed ID: 11755333
    [Abstract] [Full Text] [Related]

  • 4. Molecular design of multifunctional antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA).
    Kubo I, Fujita K, Nihei K.
    Bioorg Med Chem; 2003 Sep 15; 11(19):4255-62. PubMed ID: 12951156
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial ointments and methicillin-resistant Staphylococcus aureus USA300.
    Suzuki M, Yamada K, Nagao M, Aoki E, Matsumoto M, Hirayama T, Yamamoto H, Hiramatsu R, Ichiyama S, Iinuma Y.
    Emerg Infect Dis; 2011 Oct 15; 17(10):1917-20. PubMed ID: 22000371
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
    Candel FJ, Morales G, Picazo JJ.
    Rev Esp Quimioter; 2011 Sep 15; 24(3):127-30. PubMed ID: 21947094
    [Abstract] [Full Text] [Related]

  • 7. Alkyl gallates, intensifiers of beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus.
    Shibata H, Kondo K, Katsuyama R, Kawazoe K, Sato Y, Murakami K, Takaishi Y, Arakaki N, Higuti T.
    Antimicrob Agents Chemother; 2005 Feb 15; 49(2):549-55. PubMed ID: 15673731
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
    Huang V, Cheung CM, Kaatz GW, Rybak MJ.
    Int J Antimicrob Agents; 2010 Jan 15; 35(1):25-9. PubMed ID: 19900792
    [Abstract] [Full Text] [Related]

  • 11. Synergistic bactericidal activity of a novel dual β-lactam combination against methicillin-resistant Staphylococcus aureus.
    Altarawneh H, Alhomra T, Alharbi M, Fan Y, Derrick JP, Xia G.
    J Antimicrob Chemother; 2024 Jul 01; 79(7):1677-1682. PubMed ID: 38831599
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of 169 USA300 methicillin-resistant Staphylococcus aureus isolates to two copper-based biocides, CuAL42 and CuWB50.
    Luna VA, Hall TJ, King DS, Cannons AC.
    J Antimicrob Chemother; 2010 May 01; 65(5):939-41. PubMed ID: 20348086
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN, Kaatz GW, Rucker LR, Rybak MJ.
    J Antimicrob Chemother; 2008 Dec 01; 62(6):1305-10. PubMed ID: 18801920
    [Abstract] [Full Text] [Related]

  • 15. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Zuo GY, Zhang XJ, Han J, Li YQ, Wang GC.
    BMC Complement Altern Med; 2015 Dec 01; 15():425. PubMed ID: 26627468
    [Abstract] [Full Text] [Related]

  • 16. Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007.
    Hultén KG, Kaplan SL, Lamberth LB, Slimp K, Hammerman WA, Carrillo-Marquez M, Starke JR, Versalovic J, Mason EO.
    Infect Control Hosp Epidemiol; 2010 Feb 01; 31(2):183-90. PubMed ID: 20001603
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro time-kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin.
    Vidaillac C, Parra-Ruiz J, Rybak MJ.
    Diagn Microbiol Infect Dis; 2011 Dec 01; 71(4):470-3. PubMed ID: 22018937
    [Abstract] [Full Text] [Related]

  • 20. Emergence of SCCmec type III with variable antimicrobial resistance profiles and spa types among methicillin-resistant Staphylococcus aureus isolated from healthcare- and community-acquired infections in the west of Iran.
    Mohammadi S, Sekawi Z, Monjezi A, Maleki MH, Soroush S, Sadeghifard N, Pakzad I, Azizi-Jalilian F, Emaneini M, Asadollahi K, Pourahmad F, Zarrilli R, Taherikalani M.
    Int J Infect Dis; 2014 Aug 01; 25():152-8. PubMed ID: 24909489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.